These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1018 related items for PubMed ID: 17654743

  • 21. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 22. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
    Pirola CJ, Gianotti TF, Burgueño AL, Rey-Funes M, Loidl CF, Mallardi P, Martino JS, Castaño GO, Sookoian S.
    Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [Abstract] [Full Text] [Related]

  • 25. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
    Arendt BM, Comelli EM, Ma DW, Lou W, Teterina A, Kim T, Fung SK, Wong DK, McGilvray I, Fischer SE, Allard JP.
    Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
    [Abstract] [Full Text] [Related]

  • 26. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Papatheodorou A, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, Anastasiadou K, Terpos E.
    Metabolism; 2013 Jan; 62(1):121-6. PubMed ID: 22841522
    [Abstract] [Full Text] [Related]

  • 27. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM.
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.
    Kahraman A, Sowa JP, Schlattjan M, Sydor S, Pronadl M, Wree A, Beilfuss A, Kilicarslan A, Altinbaş A, Bechmann LP, Syn WK, Gerken G, Canbay A.
    Clin Sci (Lond); 2013 Oct; 125(8):391-400. PubMed ID: 23627434
    [Abstract] [Full Text] [Related]

  • 30. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 31. Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis.
    Risikesan J, Heebøll S, Kumarathas I, Søndergaard E, Johansen RF, Ringgaard S, Aagaard NK, Sandahl TD, Villadsen GE, Gormsen LC, Frystyk J, Jensen MD, Grønbæk H, Nielsen S.
    J Lipid Res; 2024 Jul; 65(7):100580. PubMed ID: 38901559
    [Abstract] [Full Text] [Related]

  • 32. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.
    Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M.
    Hepatology; 2008 Apr; 47(4):1167-77. PubMed ID: 18311774
    [Abstract] [Full Text] [Related]

  • 33. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H, Semela D, Ledermann M, Zimmermann A, Dufour JF.
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [Abstract] [Full Text] [Related]

  • 34. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD.
    Prostaglandins Leukot Essent Fatty Acids; 2010 Aug; 82(4-6):265-71. PubMed ID: 20189787
    [Abstract] [Full Text] [Related]

  • 35. Tissue lipid composition in fatty liver and kidney syndrome in chicks.
    Whitehead CC.
    Res Vet Sci; 1975 Jan; 18(1):32-5. PubMed ID: 1118662
    [Abstract] [Full Text] [Related]

  • 36. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS, Helzberg JH, Nachnani JS, Gurram K.
    Surg Obes Relat Dis; 2008 Jan; 4(5):612-7. PubMed ID: 18226970
    [Abstract] [Full Text] [Related]

  • 37. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.
    Gambino R, Bugianesi E, Rosso C, Mezzabotta L, Pinach S, Alemanno N, Saba F, Cassader M.
    Int J Mol Sci; 2016 Mar 31; 17(4):479. PubMed ID: 27043543
    [Abstract] [Full Text] [Related]

  • 38. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
    Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE.
    Liver Int; 2012 Feb 31; 32(2):297-302. PubMed ID: 22097893
    [Abstract] [Full Text] [Related]

  • 39. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
    Duan XY, Zhao HP, Fan JG.
    J Dig Dis; 2010 Apr 31; 11(2):94-100. PubMed ID: 20402835
    [Abstract] [Full Text] [Related]

  • 40. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
    Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma DW, Heathcote JE.
    J Hepatol; 2008 Feb 31; 48(2):300-7. PubMed ID: 18086506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.